Search research articles
Contact Us
Filters
Showing results (181-190 of 336) with videos related to
Page
of 34
Sort By:
Journal for Immunotherapy of Cancer
|
April 11, 2019
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial
Xiaotong Li, Sarah Warren, Vasiliki Pelekanou, et al.
Breast Cancer Research and Treatment
|
March 14, 2020
Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy
Theodore S Jennaro, Fang Fang, Kelley M Kidwell, et al.
Breast Cancer Research and Treatment
|
December 13, 2016
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer
Jason D Robarge, Zereunesay Desta, Anne T Nguyen, et al.
Psycho-Oncology
|
February 1, 2012
Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers
Laurel L Northouse, Darlene W Mood, Ann Schafenacker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2016
Innovations in American Society of Clinical Oncology Practice Guideline Development
Mark R Somerfield, Kari Bohlke, George P Browman, et al.
Pharmacogenomics
|
December 7, 2018
Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure
Lauren A Marcath, Kelley M Kidwell, Adam C Robinson, et al.
Science Translational Medicine
|
August 2, 2013
Breaking a vicious cycle
Daniel F Hayes, Jeff Allen, Carolyn Compton, et al.
The New England Journal of Medicine
|
August 20, 2004
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
Massimo Cristofanilli, G Thomas Budd, Matthew J Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2009
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status
Raymond Tubbs, William E Barlow, G Thomas Budd, et al.
The American Journal of Pathology
|
February 13, 2010
Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome
Malini Harigopal, William E Barlow, Greg Tedeschi, et al.
Page
of 34
Search research articles
Search
Showing results (181-190 of 336) with videos related to
Sort By:
Page
of 34
Journal for Immunotherapy of Cancer
|
April 11, 2019
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial
Xiaotong Li, Sarah Warren, Vasiliki Pelekanou, et al.
Breast Cancer Research and Treatment
|
March 14, 2020
Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy
Theodore S Jennaro, Fang Fang, Kelley M Kidwell, et al.
Breast Cancer Research and Treatment
|
December 13, 2016
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer
Jason D Robarge, Zereunesay Desta, Anne T Nguyen, et al.
Psycho-Oncology
|
February 1, 2012
Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers
Laurel L Northouse, Darlene W Mood, Ann Schafenacker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2016
Innovations in American Society of Clinical Oncology Practice Guideline Development
Mark R Somerfield, Kari Bohlke, George P Browman, et al.
Pharmacogenomics
|
December 7, 2018
Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure
Lauren A Marcath, Kelley M Kidwell, Adam C Robinson, et al.
Science Translational Medicine
|
August 2, 2013
Breaking a vicious cycle
Daniel F Hayes, Jeff Allen, Carolyn Compton, et al.
The New England Journal of Medicine
|
August 20, 2004
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
Massimo Cristofanilli, G Thomas Budd, Matthew J Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2009
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status
Raymond Tubbs, William E Barlow, G Thomas Budd, et al.
The American Journal of Pathology
|
February 13, 2010
Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome
Malini Harigopal, William E Barlow, Greg Tedeschi, et al.
Page
of 34